Morgan Stanley Annual Global Healthcare Conference

RNS Number : 1613P

Indivior PLC

30 August 2017

 

Indivior's CEO to Participate in Morgan Stanley's 15th Annual Global Healthcare Conference on September 11th

Slough, UK and Richmond, VA, August 30th, 2017 - Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will participate in Morgan Stanley's 15th Annual Global Healthcare Conference on September 11th, 2017, at 8:45 a.m. local time, in New York City. Mark Crossley, CFO, and Jason Thompson, VP of Investor Relations, will also participate. Thaxter will discuss Indivior's business and outlook. His remarks will be webcast live and the broadcast will be available on the "Investors" section of Indivior's website (www.indivior.com). If you plan on listening to the live webcast please allow sufficient time to register and download any audio software required to access the discussion.

About Indivior

Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline "Focus on you" makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more.

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: [phone] or [e-mail]

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

END

 

 

MSCOKCDPFBKKDFB